{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:23:46Z","timestamp":1790029426263,"version":"4.0.1"},"reference-count":10,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.3201\/eid3202.251553","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:46:58Z","timestamp":1771350418000},"source":"Crossref","is-referenced-by-count":3,"title":["Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom"],"prefix":"10.3201","volume":"32","author":[{"given":"Victoria H.","family":"Sheridan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Dunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Turtle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian A.","family":"Hiscox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishanthi S.","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ISARIC4C Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3202.251553-202602151945-R1","doi-asserted-by":"publisher","first-page":"105662","DOI":"10.1016\/j.jcv.2024.105662","article-title":"Human monkeypox virus: Epidemiologic review and research progress in diagnosis and treatment.","volume":"171","author":"Sun","year":"2024","journal-title":"J Clin Virol"},{"key":"key-10.3201\/eid3202.251553-202602151945-R2","unstructured":"World Health Organization. Mpox. 2025[cited 2025 Jul 27]. https:\/\/www.who.int\/health-topics\/mpox"},{"key":"key-10.3201\/eid3202.251553-202602151945-R3","doi-asserted-by":"crossref","unstructured":"Srivastava S. Laxmi, Sharma K, Sridhar SB, Talath S, Shareef J, et al. Clade Ib: a new emerging threat in the Mpox outbreak. Front Pharmacol. 2024;15:1504154. 10.3389\/fphar.2024.1504154","DOI":"10.3389\/fphar.2024.1504154"},{"key":"key-10.3201\/eid3202.251553-202602151945-R4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals.","volume":"29","author":"Zaeck","year":"2023","journal-title":"Nat Med"},{"key":"key-10.3201\/eid3202.251553-202602151945-R5","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/jama.2024.20951","article-title":"Decline of mpox antibody responses after modified vaccinia Ankara-Bavarian Nordic vaccination.","volume":"332","author":"Collier","year":"2024","journal-title":"JAMA"},{"key":"key-10.3201\/eid3202.251553-202602151945-R6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(23)00057-9","article-title":"Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study.","volume":"23","author":"Bertran","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3202.251553-202602151945-R7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.chom.2023.05.001","article-title":"Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.","volume":"31","author":"Hubert","year":"2023","journal-title":"Cell Host Microbe"},{"key":"key-10.3201\/eid3202.251553-202602151945-R8","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1038\/s41467-025-57947-8","article-title":"Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.","volume":"16","author":"Mellors","year":"2025","journal-title":"Nat Commun"},{"key":"key-10.3201\/eid3202.251553-202602151945-R9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3201\/eid3102.241300","article-title":"Short-lived neutralizing antibody responses to monkeypox virus in smallpox vaccine\u2013naive persons after JYNNEOS vaccination.","volume":"31","author":"Phipps","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3202.251553-202602151945-R10","doi-asserted-by":"publisher","first-page":"112957","DOI":"10.1016\/j.jim.2021.112957","article-title":"Impact of complement and difference of cell-based assay and ELISA in determination of neutralization capacity against mumps and measles virus.","volume":"490","author":"Brgles","year":"2021","journal-title":"J Immunol Methods"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:46:58Z","timestamp":1771350418000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/32\/2\/25-1553_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3202.251553","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}